News for hackers. Stuff that matters.
Re:The press-release conviction of a biotech CEO and its imp... by jonlucc on Wednesday October 02, 2013 @10:32PM (#6486757)
I agree that they needed the additional study (which is underway, I believe). However, I think it is important to realize the cost of another study of that size is very expensive and often small vaccine companies can't afford unplanned major studies without going back to the financial drawing board.

There are no comments on this comment yet.